ERYTHEMA
Clinical trials for ERYTHEMA explained in plain language.
Never miss a new study
Get alerted when new ERYTHEMA trials appear
Sign up with your email to follow new studies for ERYTHEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to shrink tough breast cancer before surgery
Disease control OngoingThis study is testing if adding a targeted drug called panitumumab to standard chemotherapy works better than chemotherapy alone before surgery for a fast-growing, hard-to-treat type of breast cancer. It aims to see which combination shrinks the tumor more effectively, potentiall…
Matched conditions: ERYTHEMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New immune therapy tested to keep aggressive breast cancer in check
Disease control OngoingThis study tested whether the immunotherapy drug pembrolizumab could help control advanced inflammatory or triple-negative breast cancer in patients whose disease had already responded to or stabilized with chemotherapy. The trial involved 71 participants with these aggressive fo…
Matched conditions: ERYTHEMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC